Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
440.86%
Change (1 year)
Categories
Affimed (AFMD) - Total assets
Total assets on the balance sheet as of September 2023 : $0.12 B
According to Affimed 's latest financial reports the company's total assets are $0.12 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Affimed - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.21 B | -15.78% |
| 2021-12-31 | $0.25 B | 17.96% |
| 2020-12-31 | $0.21 B | 71.72% |
| 2019-12-31 | $0.12 B | -5.29% |
| 2018-12-31 | $0.13 B | 156.51% |
| 2017-12-31 | $51.81 M | 0.98% |
| 2016-12-31 | $51.3 M | -40.84% |
| 2015-12-31 | $86.73 M | 70.16% |
| 2014-12-31 | $50.96 M | 467.81% |
| 2013-12-31 | $8.97 M | -5.63% |
| 2012-12-31 | $9.51 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $2.82 B | 2,119.17% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $19.18 M | -84.92% | 🇺🇸 USA |
 Agenus
AGEN | $0.31 B | 146.65% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.36 B | 187.84% | 🇺🇸 USA |